4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000066
Chief Executive Officer sold 28,094 shares at $12.99 ($364,941)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salzmann Peter Chief Executive Officer | 2025-04-09 | Sale | −28,094 | $12.99 | $364,941 | 1,186,512 | D |
| Open-market sales · 28,094 sh · avg $12.99 · $364,941 | |||||||
Loading xslF345X05/wk-form4_1744401896.xml…